Volitionrx (VNRX) Receivables - Net (2012 - 2025)
Volitionrx (VNRX) posted Receivables - Net of $317808.0 for Q4 2025, up 2.82% on a QoQ basis from $309085.0 in Q3 2025, and up 901.44% year-over-year from $31735.0 in Q4 2024.
Volitionrx (VNRX) Receivables - Net (2012 - 2025) Analysis & Trends
Volitionrx's Receivables - Net history runs 9 years deep, the most recent figure standing at $317808.0 for Q4 2025.
- Quarterly Receivables - Net rose 901.44% year-over-year to $317808.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $317808.0 (up 901.44% YoY) and the FY2025 annual result came in at $317808.0, up 187.42% from the prior year.
- Receivables - Net was $317808.0 for Q4 2025 at Volitionrx, up from $309085.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $317808.0 in Q4 2025 and bottomed at $5492.0 in Q3 2022.
- A 5-year average of $123083.6 and a median of $95600.5 in 2022 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2021 — Receivables - Net surged 5783.47% — and 2024, when it slumped 86.92%.
- Volitionrx's Receivables - Net stood at $12510.0 in 2021, then soared by 480.41% to $72609.0 in 2022, then jumped by 234.14% to $242617.0 in 2023, then slumped by 86.92% to $31735.0 in 2024, then surged by 901.44% to $317808.0 in 2025.
- Business Quant data shows VNRX's Receivables - Net at $317808.0 in Q4 2025, $309085.0 in Q3 2025, and $189597.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 317,808.00 |
| Dec 31, 2025 | 317,808.00 |
| Sep 30, 2025 | 309,085.00 |
| Sep 30, 2025 | 309,085.00 |
| Jun 30, 2025 | 189,597.00 |
| Jun 30, 2025 | 189,597.00 |
| Mar 31, 2025 | 187,830.00 |
| Mar 31, 2025 | 187,830.00 |
| Dec 31, 2024 | 31,735.00 |
| Dec 31, 2024 | 31,735.00 |
| Sep 30, 2024 | 312,611.00 |
| Sep 30, 2024 | 312,611.00 |
| Jun 30, 2024 | 166,262.00 |
| Jun 30, 2024 | 166,262.00 |
| Mar 31, 2024 | 133,500.00 |
| Mar 31, 2024 | 133,500.00 |
| Dec 31, 2023 | 242,617.00 |
| Dec 31, 2023 | 242,617.00 |
| Sep 30, 2023 | 34,441.00 |
| Sep 30, 2023 | 34,441.00 |